News Conference News AHA 2022 ‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE Michael O'Riordan November 06, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2022 Shelley Wood May 02, 2022
News Conference News ACC 2022 APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study Michael O'Riordan April 03, 2022
News CV Team Pro The Providence St. Vincent Medical Center Cath Lab Team L.A. McKeown September 12, 2019
News Daily News Las Muertes por Causas Cardiovasculares de los Astronautas del Proyecto Apolo Plantean Cuestiones de Seguridad CV en el Espacio Profundo Michael O'Riordan August 01, 2016
News Daily News Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space Michael O'Riordan August 01, 2016
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013
Presentation Células Adiposas contra el STEMI: Ensayos Aleatorizados APOLLO y ADVANCE Presenter: E. Duckers January 30, 2012
News Conference News Cell Therapy 2012 Expedited Cell Therapy After STEMI Shows Promise January 29, 2012
Presentation Adipose Cells for STEMI: APOLLO and ADVANCE Randomized Trials Presenter: E. Duckers January 29, 2012
Presentation Cell Therapy 2012 Long-term Follow-up of Patients with AMI Treated with Adipose-Derived Stem Cells (APOLLO) Presenter: Henricus J. Duckers January 25, 2012